FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Quick Stats
Jan 30, 202659.2
AI Score
HOLD0.22
Volume Ratio
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
FBLG Stock Summary
Last updated Jan 30, 2026
FBLG is currently trading at $0.3318, positioned below its 200-day moving average of $0.57, suggesting bearish momentum. The stock has a 52-week range of $0.2201 to $2.
Technical Analysis: The 50-day moving average stands at $0.3, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.862, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.205, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates FBLG at 59.2/100 with a HOLD recommendation.
FBLG (FibroBiologics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.862 |
| CMF (20) | 0.205 |
| ROC (10) | -1.689 |
| ADX (14) | 35.885 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.016 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -81.803 |
| MFI (14) | 38.594 |
FBLG Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
FBLG Price vs Max Options Open Interest
FBLG Max Change In Options Open Interest
FBLG Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FBLG Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FBLG Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FBLG Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FibroBiologics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
FBLG Moving Averages Analysis
FibroBiologics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
FBLG (FibroBiologics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.35 |
| 20 | 0.33 |
| 30 | 0.31 |
| 50 | 0.3 |
| 100 | 0.38 |
| 200 | 0.57 |
FBLG Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 23.8 million |
| Earnings/Share ($) | -0.48 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.485 |
| EPS Estimate Next Year ($) | -0.415 |
| WallStreet Target Price ($) | 7 |
| Most Recent Quarter |